Targeting STAT3 has Therapeutic Potential to regain Nilotinib response in parental and Resistant Chronic Myeloid Leukemia Cells


KAYMAZ B. , SELVİ GÜNEL N. , BOZOK ÇETİNTAŞ V. , ADAN GÖKBULUT A., BARAN Y., GÜNDÜZ C. , et al.

3rd EACR-Sponsored Anticancer Agent Development Congress, 18 - 19 Mayıs 2015